XML 45 R31.htm IDEA: XBRL DOCUMENT v3.22.2.2
Income Tax Matters (Tables)
9 Months Ended
Sep. 30, 2022
Income Tax Disclosure [Abstract]  
Schedule of deferred tax assets and liabilities

Significant components of the Company’s deferred tax assets and liabilities as of September 30, 2022, and December 31, 2021, were as follows:

(In thousands)

    

September 30, 2022

    

December 31, 2021

Deferred tax assets:

 

  

 

  

Loss carryforwards

$

2,235

$

2,244

Capitalized costs

 

91

 

127

Stock option granted

1,001

1,060

Policy acquisition costs

5,705

3,640

Charitable contribution carryforward

General business credits

6

6

Derivative option allowance

510

Sec 163(j) limitation

173

171

Benefit reserves

 

10,871

 

6,720

Property and equipment

73

33

Impairments

403

Unrealized losses on investments

14,049

Other

1,464

1,464

Total deferred tax assets

 

36,071

 

15,975

Less valuation allowance

 

(31,363)

 

(14,431)

Total deferred tax assets, net of valuation allowance

 

4,708

 

1,544

Deferred tax liabilities:

 

  

 

  

Unrealized losses on investments

 

 

1,084

Intangible assets

 

147

 

147

Derivative option allowance

 

3,810

 

Bond Discount

751

313

Property and equipment

 

 

Total deferred tax liabilities

 

4,708

 

1,544

Net deferred tax assets

$

$

Schedule of effective tax rate reconciliation

There was income tax expense of $1.3 million and tax benefit of $0.4 million for the three months ended September 30, 2022, and 2021, respectively. There was income tax expense of $3.8 million and $1.8 million for the nine months ended September 30, 2022, and 2021, respectively. This differed from the amounts computed by applying the statutory U.S. federal income tax rate of 21% to pretax income, as a result of the following:

Three months ended September 30, 

Nine months ended September 30, 

(In thousands)

    

2022

    

2021

    

2022

    

2021

Computed expected income tax benefit (expense)

$

(796)

$

749

$

(2,305)

$

1,676

Reduction (increase) in income taxes resulting from:

 

 

  

 

 

  

IMR and reinsurance

176

65

158

240

Nondeductible expenses

(3)

1

(8)

4

Change in valuation allowance

 

(641)

 

333

 

(1,693)

3,266

Dividends received deduction

(1)

(6)

Deferred tax adjustment

14

Subtotal of increases

 

(454)

 

398

 

(1,543)

 

3,504

Tax benefit (expense)

$

(1,250)

$

351

$

(3,848)

$

(1,828)